Issue Ebookcover storyIssue CoverIssue Contents
Latest Issue
Online FirstList of IssuesDocument Types
- Abstract:ObjectiveTo explore the mechanism through which Wuling San manages primary open-angle glaucoma (POAG) based on the cyclic adenosine monophosphate (cAMP)/ protein kinase A (PKA)/aquaporins (AQPs) signaling pathway, and to identify the molecular targets of Wuling San for regulating aquaporin 1 (AQP1) membrane translocation and improving aqueous humor metabolism.MethodsIn the animal experiments, a rat model of chronic ocular hypertension was established by anterior chamber microbead injection. Sixty SD rats were assigned into blank, model, low-, medium-, and high-dose (2.16, 4.32, and 8.64 g·kg-1, respectively) Wuling San, and acetazolamide (0.045 g·kg-1) groups. Rats were administrated with corresponding agents by gavage for 2 consecutive weeks. Intraocular pressure (IOP) was measured in each group. Terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) was employed to detect the apoptosis of retinal ganglion cells (RGCs). Hematoxylin-eosin (HE) staining was performed to observe retinal pathological morphology. Immunohistochemistry (IHC) was adopted to detect AQP1 expression in the ciliary body. Real-time quantitative polymerase chain reaction(Real-time PCR) was employed to quantify the mRNA levels of PKA and AQP1 in the ciliary body. Enzyme-linked immunosorbent assay (ELISA) was performed to measure the levels of cAMP, PKA, and AQP1 in the ciliary body. In the cell experiments, rat trabecular meshwork cells were treated with transforming growth factor(TGF)-β2 (2.5 μg·L-1) to simulate the pathological state of POAG. Cells were allocated into blank, model (7.5% blank serum), Wuling San-containing serum (7.5%), cAMP inhibitor (50 μmol·L-1 SQ22536), cAMP agonist (10 μmol·L-1 Forskolin), acetazolamide (10 μmol·L-1 acetazolamide sodium), and Wuling San combined with agonist (7.5% Wuling San-containing serum +10 μmol·L-1 Forskolin) group. The cell counting kit-8 (CCK-8) assay was used to screen the optimal intervention concentration of Wuling San-containing serum and intervention duration. ELISA was employed to measure the levels of cAMP, matrix metalloproteinase-9 (MMP-9), fibronectin (FN), laminin (LN), tumor necrosis factor-α (TNF-α), and interleukin-6 (IL-6). Real-time PCR was employed to quantify the mRNA levels of PKA and AQP1, and Western blot to determine the protein levels of PKA, AQP1, collagen type Ⅰ (ColⅠ), and collagen type Ⅳ (ColⅣ). Immunofluorescence (IF) staining was used to examine the level of AQP1 membrane translocation.ResultsThe animal experiment results showed that compared with the blank group, the model group exhibited elevated IOP, increased apoptotic RGCs, obvious retinal structural injury, and decreased expression of cAMP, PKA, and AQP1 (P<0.05, P<0.01). Compared with the model group, Wuling San reduced IOP, alleviated RGC apoptosis and retinal injury, and down-regulated the expression of cAMP, PKA, and AQP1 in the ciliary body in a dose-dependent manner (P<0.05, P<0.01). The cell experiments verified that compared with the blank group, the model group exhibited weakened activity of the cAMP/PKA/AQP1 pathway, down-regulated expression of cAMP, PKA, and AQP1, reduced AQP1 membrane translocation, a lowered level of MMP-9, and elevated levels of FN, LN, TNF-α, IL-6, ColⅠ, and ColⅣ(P<0.05, P<0.01). Compared with the model group, Wuling San-containing serum activated the cAMP/PKA/AQP1 pathway in trabecular meshwork cells, significantly increased the cAMP level, up-regulated the mRNA and protein levels of PKA and AQP1, promoted AQP1 membrane translocation, increased the MMP-9 level to enhance extracellular matrix (ECM) degradation, and lowered the FN, LN, TNF-α, IL-6, ColⅠ, and ColⅣ levels to reduce ECM deposition and release of inflammatory factors. Combined use with the cAMP agonist strengthened the above effects (P<0.01). Acetazolamide exerted no obvious regulatory effect on the cAMP/PKA/AQP1 pathway.ConclusionWuling San exerts bidirectional regulatory effects on POAG. It inhibits the cAMP/PKA/AQP1 pathway in the ciliary body to reduce aqueous humor secretion and lower IOP. Meanwhile, it activates this pathway in trabecular meshwork to promote AQP1 membrane translocation, relieve trabecular meshwork fibrosis, and ameliorate aqueous humor outflow. Its therapeutic mechanism is closely related to the regulation of the cAMP/PKA/AQPs signaling pathway.Keywords:primary open-angle glaucoma;cyclic adenosine monophosphate/protein kinase a/aquaporins (cAMP/PKA/AQPs) signaling pathway;membrane translocation;chronic ocular hypertension42|15|0<HTML><H-PDF> <L-PDF> <XML>Updated:2026-11-17
Protective Effects and Molecular Mechanisms of Sini Tang in Treating Ponatinib-induced Heart Failure in Mice AI Introduction
Abstract:ObjectiveTo investigate the protective effect and molecular mechanisms of the classical prescription Sini Tang (SNT) in treating heart failure (HF) induced by ponatinib (PNT), a third-generation multi-target tyrosine kinase inhibitor used for treating hematological malignancies, based on the traditional efficacy of warming the middle to dispel cold and restoring Yang to save from collapse.MethodsThe HF model in mice was established by gavage of PNT, and SNT was used for intervention. Fifty-four mice were randomized into a control group, a model group, high-dose (10.4 g·kg-1), medium-dose (5.2 g·kg-1), and low-dose (2.6 g·kg-1) SNT groups, and a captopril (15 mg·kg-1) group. A high-resolution small animal ultrasound imaging system was used to evaluate the cardiac structure and function of mice. Transcriptomics combined with network pharmacology was utilized to explore the pathways involved in the SNT treatment of PNT-induced HF. Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) was adopted to observe the apoptosis of mouse cardiomyocytes. Immunohistochemistry was employed to detect the expression of cleaved cysteinyl aspartate-specific proteinase-3 (cleaved Caspase-3) in mouse cardiomyocytes. The serum levels of brain natriuretic peptide (BNP), cardiac troponin T (cTnT), tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), and malondialdehyde (MDA) in mice were determined by enzyme-linked immunosorbent assay (ELISA). Western blot was conducted to determine the expression levels of mitogen-activated protein kinase (MAPK) signaling pathway-related proteins, including extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), p38 MAPK, Fos proto-oncogene (c-FOS), and their phosphorylated forms in the cardiac tissue.ResultsCompared with the model group, SNT interventions at all doses increased LVEF and LVFS (P<0.01) and reduced the left ventricular end-systolic diameter (LVIDs) (P<0.05, P<0.01). Furthermore, SNT decreased the heart index (P<0.05, P<0.01) and ameliorated histopathological lesions in the cardiac tissue. Integrated transcriptomic and network pharmacology analyses revealed that the pivotal mechanisms underlying the protective effects of SNT against PNT-induced HF were closely associated with cardiomyocyte apoptosis, as well as the MAPK and TNF signaling pathways. SNT treatment inhibited PNT-induced cardiomyocyte apoptosis and the expression of cleaved Caspase-3 in the cardiac tissue (P<0.05, P<0.01). Furthermore, it reduced the serum levels of BNP, cTnT, TNF-α, IL-6, and MDA (P<0.05, P<0.01), and down-regulated the relative protein levels of MAPK pathway molecules, including p-JNK/JNK, p-ERK/ERK, p-p38 MAPK/p38 MAPK, and c-FOS, in the cardiac tissue (P<0.05, P<0.01).ConclusionSNT intervention can regulate the MAPK signaling pathway, inhibit myocardial injury and cardiomyocyte apoptosis, and alleviate oxidative stress and inflammatory responses to exert the cardioprotective effect, thereby effectively ameliorating PNT-induced HF in mice. This study provides a reference for traditional Chinese medicine in alleviating the cardiotoxic effects of chemotherapeutic drugs and lays a foundation for the in-depth development and novel clinical application of classical prescriptions.Keywords:Sini tang;heart failure;ponatinib;transcriptomics;molecular docking;mitogen-activated protein kinase (MAPK) pathway;cardiomyocyte apoptosis51|27|0<HTML><H-PDF> <L-PDF> <XML>Updated:2026-11-17- Abstract:ObjectiveTo observe the inhibitory effect of Astragali Radix saponins-Curcumae Rhizoma oil component on liver metastasis of colorectal cancer in mice and to explore the mechanism of the inhibitory effect through regulating the vascular endothelial cadherin (VE-cadherin)/β-catenin pathway mediated by neutrophil extracellular traps (NETs).MethodsBalb/c mice were randomized into sham, model, low-dose and high-dose (0.1 g·kg-1 and 0.2 g·kg-1, respectively) Astragali Radix saponins, low-dose and high-dose (0.1 g·kg-1 and 0.2 g·kg-1, respectively) Curcumae Rhizoma component, and Astragali Radix saponins-Curcumae Rhizoma oil (0.2 g·kg-1) groups. After 14 days of treatment, mice were sacrificed, and the tumor and liver tissue samples were collected for observation of the histopathological morphology by hematoxylin-eosin (HE) staining. The expression of NETs and VE-cadherin/β-catenin-related proteins was detected by Western blot, and that of citrullinated histone H3 (CitH3) and myeloperoxidase (MPO) in the liver tissue was detected through immunofluorescence staining. The mRNA levels of VE-cadherin, β-catenin, matrix metalloproteinase-9 (MMP-9) were quantified by Real-time PCR. The binding energy of the active ingredients of Astragali Radix saponins-Curcumae Rhizoma oil with the NETs regulatory protein peptidyl arginine deiminase 4 (PAD4) was predicted by molecular docking, and the molecular docking results were verified in vivo.ResultsCompared with that in the sham group, the body weight of mice in the model group reduced (P<0.01). After administration of the components, the body weight and quality of life of mice with liver metastasis were significantly improved. Extensive metastatic lesions and obvious pathological changes were observed in the liver tissue of mice in the model group. Compared with the model group, the treatment groups exhibited reduced liver metastatic foci to different degrees, which reached a significant level in the Astragali Radix saponins-Curcumae Rhizoma component group (P<0.01). Astragali Radix saponins-Curcumae Rhizoma oil inhibited the expression of NETs-related proteins neutrophil elastase (NE), MPO, and CitH3 in liver metastatic foci (P<0.05, P<0.01). Both Astragali Radix saponins and Curcumae Rhizoma component exhibited strong binding affinity to PAD4 and suppressed the expression of PAD4 (P<0.01). Meanwhile, after administration of the components, the expression of VE-cadherin, β-catenin, and MMP-9 at protein and mRNA levels in liver metastatic foci of mice with liver metastasis were downregulated (P<0.05, P<0.01).ConclusionAstragali Radix saponins-Curcumae Rhizoma component inhibits liver metastasis of colorectal cancer by inhibiting the generation of NETs and its mediated VE-cadherin/β-catenin pathway, which provides a basis for the development of innovative anti-tumor metastasis drugs based on Astragali Radix-Curcumae Rhizoma.Keywords:Astragali Radix Saponins-Curcumae Rhizoma oil;component;neutrophil extracellular traps (NETs);VE-cadherin/β-catenin;liver metastasis of colorectal cancer38|12|0<HTML><H-PDF> <L-PDF> <XML>Updated:2026-11-17
- Abstract:ObjectiveTo investigate the effects and mechanisms of Jianpi Huogu prescription (JPHGP) in treating steroid-induced osteonecrosis of the femoral head (SONFH) by suppressing adipogenesis while promoting osteogenesis and angiogenesis, through an integrated approach combining animal experiments, cell experiments, and network pharmacology.MethodsIn the animal experiments, 60 Sprague-Dawley (SD) rats (6-8 weeks old) were randomly assigned into six groups: blank control, model, low-, medium-, and high-dose (2.5, 5, and 10 g·kg-1, respectively) JPHGP, and Tongluo Shenggu prescription (TLSG, 0.54 g·kg-1) groups. The SONFH model was established with methylprednisolone sodium succinate (MPS) and lipopolysaccharide (LPS). After 8 weeks of treatment, the therapeutic effects were evaluated by mechanical pain threshold testing, inclined plate test, serum lipid parameters, femoral head histopathology and imaging analysis, and ink perfusion assay. In the cell experiments, bone marrow mesenchymal stem cells (BMSCs) and endothelial progenitor cells (EPCs) were treated with dexamethasone (DEX, 5 mg·L-1) to simulate the SONFH pathological environment. The direct effects of JPHGP (1, 10, and 100 μg·L-1) on adipogenic/osteogenic differentiation of BMSCs and angiogenic function of EPCs were observed. Transwell and scratch assays were employed to evaluate the migration of BMSCs and EPCs, respectively. Osteogenic differentiation was evaluated by alkaline phosphatase activity and Alizarin Red staining. Adipogenic differentiation was detected by oil red O staining, and angiogenic capacity was measured by tube formation assay. To decipher the therapeutic mechanisms, network pharmacology analysis was performed on BMSC transcriptome data from the GEO database, which was combined with literature research to predict core targets of JPHGP against SONFH, followed by validation in vivo and in vitro.ResultsThe animal experiment results showed that compared with the blank control group, model rats exhibited decreased mechanical pain thresholds and maximal inclination angles (P<0.01), reduced osteocyte counts with increased empty lacunae in the femoral head (P<0.01), decreased bone mineral density (BMD), trabecular thickness (Tb.Th), trabecular number (Tb.N), and bone volume fraction (BV/TV), increased trabecular separation (Tb.Sp) and bone surface/bone volume (BS/BV) ratio (P<0.01), diminished ink perfusion area (P<0.01), elevated levels of triglycerides (TG), total cholesterol (TC), low-density lipoprotein (LDL), and apolipoprotein B (ApoB), and declined levels of high-density lipoprotein (HDL) and apolipoprotein A1 (ApoA1) (P<0.01). Compared with the model group, JPHGP 5 and 10 g·kg-1 could significantly increase the mechanical pain threshold and the maximum tilt angle of the inclined plate (P<0.05, P<0.01), increase the number of osteocytes in the femoral head, decrease the number of empty bone lacunae (P<0.05, P<0.01), increase BMD, Tb.Th, Tb.N and BV/TV, decrease Tb.Sp and BS/BV (P<0.05, P<0.01), increase the ink perfusion area in the femoral head (P<0.01), decrease the contents of serum TG, TC, LDL and ApoB, and increase the contents of HDL and ApoA1 (P<0.05, P<0.01). The cell experiment results showed that DEX (5 mg·L-1) promoted the adipogenesis of BMSCs while inhibiting the migration and osteogenesis of BMSCs and the angiogenesis of EPCs (P<0.01). JPHGP (1, 10, and 100 μg·L-1) dose-dependently enhanced cell migration, restored osteogenic and tube-forming capacities, and suppressed adipogenic differentiation (P<0.05, P<0.01). Network pharmacology and transcriptomic analysis predicted phosphodiesterase 10A (PDE10A), bone morphogenetic protein 2 (BMP2), and vascular endothelial growth factor (VEGF) as key targets of JPHGP in intervening in DEX-BMSCs. DEX suppressed the expression of PDE10A, BMP2, and VEGF while upregulating the expression of cyclic adenosine monophosphate (cAMP) and peroxisome proliferator-activated receptor-γ (PPARγ) in BMSCs (P<0.01). JPHGP reversed these effects dose-dependently (P<0.05, P<0.01), which, however, were abolished by PDE10A inhibitors or PPARγ agonists. These findings were further confirmed in the necrotic femoral head tissue from SONFH rats. Additionally, JPHGP elevated the expression of fatty acid-binding protein 4 (FABP4, a late adipogenic marker), Collagen Ⅰ(ColⅠ), and CD31 (a vascular endothelial cell-specific marker) (P<0.05, P<0.01).ConclusionJPHGP activates PDE10A to degrade cAMP, thereby suppressing PPARγ production and subsequently promoting BMP2 and VEGF generation, ultimately achieving multi-target regulation of adipogenesis, osteogenesis, angiogenesis to reconstruct the lipid-bone-blood homeostasis. This study provides a scientific basis for the effective treatment of early-stage osteonecrosis of the femoral head.Keywords:steroid-induced osteonecrosis of the femoral head;Jianpi Huogu prescription;adipogenesis inhibition-angiogenesis-osteogenesis;phosphodiesterase 10A (PDE10A)/cyclic adenosine monophosphate (cAMP)/peroxisome proliferator-activated receptor-γ (PPARγ)/vascular endothelial growth factor (VEGF)/bone morphogenetic protein 2 (BMP2) signaling axis58|18|0<HTML><H-PDF> <L-PDF> <XML>Updated:2026-11-17
Shunwei Jiangni Prescription Treats Reflux Esophagitis by Regulating Esophageal Microecology and Inhibiting TLR4/NF‑κB Signaling Pathway AI Introduction
Abstract:ObjectiveTo investigate, from the integrated perspective of the esophageal microbiota-metabolite-innate immunity-epithelial barrier axis, the mechanisms by which Shunwei Jiangni prescription (SWJN) alleviates esophageal mucosal inflammatory injury in the rat model of reflux esophagitis (RE), and to verify the mediating role of the Toll-like receptor 4 (TLR4)/nuclear factor-κB (NF-κB) signaling pathway in the therapeutic effect of SWJN.MethodsSixty SPF-grade male Wistar rats were subjected to esophago-duodenal anastomosis combined with multiple stressors (irregular feeding, alternating gavage with 40 ℃ and 4 ℃ water, and tail-clamping irritation) to establish an RE model, and divided into blank (NC), sham-operated, model and SWJN low-, medium- and high-dose groups (4.25, 8.51 and 17.01 g·kg-1, 10 rats per group), gavaged twice daily for 4 weeks; another 10 rats were used to prepare SWJN-containing serum. In vitro, HET-1A cells were injured by 500 μmol·L-1 glycochenodeoxycholic acid (GCDCA) under acidic conditions and treated with TAK-242 or lipopolysaccharide (LPS). Hematoxylin-eosin (HE) staining, 16S rRNA sequencing, untargeted metabolomics, network pharmacology, enzyme-linked immunosorbent assay (ELISA), Real-time quantitative polymerase chain reaction(Real-time PCR), Western blot, and immunofluorescence were employed to assess esophageal injury, microbiota and metabolite composition, core pathways, inflammatory and mucosal repair factors, tight junction proteins, key molecules of the TLR4/NF-κB pathway, and M1 (cluster of differentiation 86, CD86)/M2 (cluster of differentiation 206, CD206) macrophage polarization.ResultsCompared with the NC group, the model group showed retarded body weight gain, an increased percentage of esophageal acid exposure time, thickened esophageal epithelium with inflammatory cell infiltration and fibrous proliferation, and an increased total pathological score (P<0.01). Compared with the model group, the medium- and high-dose SWJN groups showed increased body weight gain, a decreased percentage of esophageal acid exposure time, and a decreased total pathological score (P<0.05). Compared with the NC group, the model group showed enrichment of opportunistic taxa such as Streptococcus, depletion of beneficial taxa such as Lactococcus_A, elevated levels of pro-inflammatory metabolites such as arachidonic acid, and reduced protective metabolites such as glutamine (P<0.05). Compared with the model group, the high-dose SWJN group showed a microbiota structure approaching that of the NC group, with pro-inflammatory metabolites declining and protective metabolites recovering (P<0.05). Compared with the NC group, the model group showed increased expression of TLR4 and myeloid differentiation factor 88 (MyD88), increased phosphorylation of NF-κB p65 (p-NF-κB p65), decreased expression of NF-κB inhibitor α (IκBα) and increased phosphorylation of IκBα (p-IκBα), elevated levels of interleukin (IL)-1β, IL-6, tumor necrosis factor-α (TNF-α), and inducible nitric oxide synthase (iNOS), declined levels of IL-10, epidermal growth factor (EGF), transforming growth factor-β1 (TGF-β1), and arginase 1 (ARG1), and an increased M1/M2 ratio (P<0.01). All these indices were reversed in the SWJN groups (P<0.05). In the TAK-242 experiment, compared with the NC group, GCDCA-treated cells showed increased expression of TLR4 and MyD88, elevated levels of pro-inflammatory cytokines, and down-regulated transcription of zonula occludens-1 (ZO-1), Occludin, Claudin-1, Claudin-4, and Claudin-5 (P<0.01). Compared with the GCDCA group, both the SWJN-containing serum and TAK-242 inhibited pathway activation, reduced pro-inflammatory cytokines, and restored the membrane continuity of ZO-1 and occludin (P<0.01). In the LPS rescue experiment, even when the pathway was over-activated, pretreatment with SWJN-containing serum still inhibited pathway activation and repaired the barrier (P<0.01).ConclusionSWJN improves the local microenvironment by correcting esophageal microbiota-metabolite disturbance, inhibits TLR4/NF-κB signaling activation, promotes M2 macrophage polarization and repairs the esophageal epithelial tight junction barrier, thereby alleviating esophageal inflammatory injury in RE. The bidirectional pharmacological validation indicates that the TLR4/NF-κB pathway is an essential mediator of the efficacy of SWJN.Keywords:Shunwei Jiangni prescription;reflux esophagitis;Toll-like receptor 4/nuclear factor-κB (TLR4/NF-κB) signaling pathway;esophageal microbiota;metabolomics36|18|0<HTML><H-PDF> <L-PDF> <XML>Updated:2026-11-17Geling Baiju Granules Improve Glucose Metabolism in Mouse Model of CKM Syndrome by Regulating Microbiota-Gut-Metabolism Axis AI Introduction
Abstract:ObjectiveTo investigate the mechanism by which Geling Baiju granules ameliorate glucose metabolism disorder in a mouse model of cardiovascular-kidney-metabolic (CKM) syndrome through regulation of the gut microbiota and its metabolic functions.MethodsAn stage 2 CKM syndrome model was established by feeding fifty 8-week-old male specific pathogen-free (SPF) db/db mice a standard chow diet, leveraging their spontaneous disease phenotype. Successfully modeled mice were randomly assigned into model, low-, medium-, and high-dose (5.23, 10.45, and 20.90 g·kg-1, respectively) Geling Baiju granules, and dapagliflozin (1.03 mg·kg-1) groups (n=10 per group). An additional group of db/m mice served as the normal control. All interventions were administered via gavage for 8 weeks. Body mass, abdominal circumference, water intake, food intake, and 24-h urine volume were monitored. Fasting blood glucose (FBG) and fasting insulin (FINS) were measured to calculate the homeostasis model assessment of insulin resistance (HOMA-IR). The urine albumin-to-creatinine ratio (UACR) was assessed to evaluate the renal function. Hematoxylin-eosin (HE) staining and Alcian blue-periodic acid-Schiff (AB-PAS) staining were employed to observe pathological morphology and the mucus barrier in the colonic tissue. Fecal samples were collected for metagenomic sequencing to analyze gut microbiota structure (including α/β diversity) and Kyoto Encyclopedia of Genes and Genomes (KEGG) functional pathways.ResultsCompared with the normal group, the model group showed increased body mass, FBG, FINS, HOMA-IR, and UACR levels (P<0.05), presenting a typical phenotype of stage 2 CKM syndrome. Compared with the model group, medium and high doses of Geling Baiju granules reduced the body mass and abdominal circumference (P<0.05), ameliorated polydipsia, polyphagia, and polyuria, lowered FINS and HOMA-IR levels (P<0.05, P<0.01), and decreased the UACR (P<0.05). HE and AB-PAS staining revealed that Geling Baiju granules alleviated inflammatory infiltration in the colonic mucosa, restored goblet cell structure, and improved mucus secretion. Microbiota analysis indicated that the granules partially restored the reduced Firmicutes/Bacteroidetes ratio observed and inhibited the abnormal expansion of Proteobacteria and Campylobacterota in model mice (P<0.05). KEGG functional annotation showed that Geling Baiju granules upregulated microbial gene functions related to carbohydrate transport/metabolism and lipid metabolism, while downregulating the abundance of pathways associated with cardiovascular diseases, endocrine/metabolic diseases, and the immune system.ConclusionGeling Baiju granules can ameliorate glucose metabolism disorder, obesity, and early renal injury in the mouse model of stage 2 CKM syndrome by reshaping the gut microbiota structure, repairing the intestinal mucosal barrier, and modulating core microbiota-mediated functional pathways such as carbohydrate metabolism and immune-inflammatory responses.Keywords:Geling Baiju granules;gut microbiota;cardiovascular-kidney-metabolic (CKM) syndrome;glucose metabolism;intestinal barrier33|19|0<HTML><H-PDF> <L-PDF> <XML>Updated:2026-11-17Junren Bufei Yixin Granules Ameliorate Monocrotaline-induced Pulmonary Hypertension in Rats by Regulating cGAS/STING/NF-κB Signaling Pathway AI Introduction
Abstract:ObjectiveTo investigate the therapeutic effects and mechanisms of Junren Bufei Yixin granules (JBYG) on monocrotaline (MCT)-induced pulmonary hypertension (PH) in rats based on the cyclic guanosine monophosphate-adenosine monophosphate (GMP-AMP) synthase (cGAS)/stimulator of interferon genes (STING)/nuclear factor-kappa B (NF-κB) signaling pathway.MethodsSixty male Sprague-Dawley (SD) rats were randomized into six groups (n=10 per group): normal control, MCT model, sildenafil (0.025 g·kg-1), and low-, medium-, and high-dose (4.275, 8.55, 17.1 g·kg-1, respectively) JBYG. The rat model of PH was established by a single intraperitoneal injection of MCT at 60 mg·kg-1. Drugs were administered via gavage once daily for 21 consecutive days, starting 1 h post-modeling. Small-animal echocardiography and right heart catheterization via the external jugular vein were employed to determine the echocardiographic and hemodynamic parameters: pulmonary artery acceleration time (PAAT), pulmonary ejection time (PET), tricuspid annular plane systolic excursion (TAPSE), right ventricular systolic pressure (RVSP), and right ventricular hypertrophy index (RVHI). Pathological alterations in pulmonary arterioles were observed after hematoxylin-eosin (HE) staining. The expression of α-smooth muscle actin (α-SMA) in pulmonary arteries was detected by immunofluorescence. Myocardial fibrosis and cardiomyocyte hypertrophy were assessed via Masson's trichrome and wheat germ agglutinin (WGA) staining, respectively. The levels of interleukin-1β (IL-1β), interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α) in the lung tissue were determined by enzyme-linked immunosorbent assay (ELISA). The expression levels of proteins associated with the cGAS/STING/NF-κB signaling pathway were quantified by Western blot.ResultsCompared with the normal control group, the MCT model group exhibited decreased PAAT/PET and TAPSE (P<0.01), increased RVSP and RVHI (P<0.01), and noticeable thickening of the pulmonary arteriole walls, with marked elevations in wall thickness percentage (WT), wall area percentage (WA), and pulmonary vascular muscularization rate (P<0.01). Additionally, the MCT model group showed severe myocardial fibrosis and enlargement of cardiomyocyte cross-sectional areas (P<0.01), elevated levels of IL-1β, IL-6, and TNF-α in the lung tissue (P<0.01), and upregulated protein levels of cGAS, phosphorylation(p)-STING/STING, and p-NF-κB/NF-κB (P<0.01). Compared with the MCT model group, the treatment groups demonstrated increased PAAT and PAAT/PET (P<0.05, P<0.01), reduced RVSP and RVHI (P<0.05, P<0.01), and thinned pulmonary arteriole walls, with reductions in WT, WA, and pulmonary vascular muscularization rate (P<0.05, P<0.01). Furthermore, the treatment groups demonstrated attenuated myocardial fibrosis and cardiomyocyte hypertrophy (P<0.05, P<0.01), declined levels of IL-1β, IL-6, and TNF-α in the lung tissue (P<0.05, P<0.01), and downregulated protein levels of cGAS, p-STING/STING, and p-NF-κB/NF-κB (P<0.05, P<0.01).ConclusionJBYG can alleviate MCT-induced pulmonary vascular remodeling and right ventricular dysfunction in the rat model of PH by suppressing pulmonary inflammation via the cGAS/STING/NF-κB signaling pathway.Keywords:Junren Bufei Yixin granules;pulmonary hypertension;cyclic guanosine monophosphate-adenosine monophosphate (GMP-AMP) synthase (cGAS)/stimulator of interferon genes (STING)/nuclear factor-kappa B (NF-κB) signaling pathway;pulmonary vascular remodeling;inflammatory response41|7|0<HTML><H-PDF> <L-PDF> <XML>Updated:2026-11-17Guanxinshu Prescription Restores Efferocytosis to Alleviate Atherosclerosis in ApoE⁻/⁻ Mice by Inhibiting IL-18/MAPK Pathway AI Introduction
Abstract:ObjectiveTo explore the effect and mechanism of Guanxinshu prescription (GXSP) on reducing inflammatory response in atherosclerosis (AS) in apolipoprotein E knockout (ApoE-/-) mice.MethodsForty SPF-grade male ApoE-/- mice were fed a high-fat diet for 12 weeks for the modeling of AS, and then they were randomized into the model, low-, medium-, and high-dose (1.5, 3, and 6 g·kg-1, respectively) GXSP, and atorvastatin (5×10-3 g·kg-1) groups, with 8 mice in each group. Additional eight C57BL/6J mice served as the normal group. After 4 weeks of intervention, the serum levels of total cholesterol (TC), triglyceride (TG), low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein cholesterol (HDL-C) were measured. Superoxide dismutase (SOD) activity and malondialdehyde (MDA) content in the aortic tissue were determined. Serum levels of tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), and interleukin-18 (IL-18) were determined by enzyme-linked immunosorbent assay (ELISA). Aortic plaque area and morphology were observed via oil red O and hematoxylin-eosin (HE) staining. The protein levels of tyrosine kinase receptor (AXL), Mer receptor tyrosine kinase (MERTK), tyrosine-protein kinase receptor TYRO3, milk fat globule-epidermal growth factor 8 (MFGE8), c-Jun N-terminal kinase (JNK), nuclear factor-κB p65 (NF-κB p65), p38 mitogen-activated protein kinase (MAPK), and extracellular signal-regulated kinase 1/2 (ERK1/2) in the aortic tissue was analyzed by Western blot. Immunohistochemistry was performed to detect α-smooth muscle actin (α-SMA) and fibronectin expression in the aortic sinus. Immunofluorescence assay was used to examine the expression of cluster of differentiation 68 (CD68) and brain-specific angiogenesis inhibitor 1 (BAI1) in aortic plaques.ResultsCompared with the normal group, the model group had dyslipidemia, increased aortic plaque area (P<0.01), elevated serum levels of TNF-α, IL-1β, and IL-18 (P<0.01), decreased MDA content and SOD activity in the aorta (P<0.05,P<0.01), upregulated expression of α-SMA, fibronectin, JNK, NF-κB p65, p38 MAPK, and ERK1/2 (P<0.05, P<0.01), downregulated expressions of AXL, MERTK, TYRO3, and MFGE8 (P<0.01), increased CD68 fluorescence intensity and decreased BAI1 fluorescence intensity (P<0.01). Compared with the model group, GXSP groups and the statin group exhibited alleviated dyslipidemia, reduced aortic plaque area (P<0.05, P<0.01). The high-dose GXSP group showed declined serum levels of TC, TG, LDL-C, IL-1β, TNF-α, IL-18, and MDA (P<0.01), increased HDL-C level and SOD activity (P<0.01), upregulated expression of α-SMA, fibronectin, TYRO3, and MFGE8 (P<0.05, P<0.01), downregulated expression of JNK, NF-κB p65, p38 MAPK, and ERK1/2 (P<0.01), weakened fluorescence intensity of CD68 and enhanced fluorescence intensity of BAI1 (P<0.01). The statin group showed declined serum levels of TC, TG, LDL-C, IL-1β, TNF-α, IL-18, and MDA (P<0.05, P<0.01), increased HDL-C level and SOD activity (P<0.05, P<0.01), upregulated expression of α-SMA, fibronectin, AXL, MERTK, TYRO3, and MFGE8 (P<0.05, P<0.01), downregulated expression of JNK, NF-κB p65, p38 MAPK, and ERK1/2 (P<0.01), decreased fluorescence intensity of CD68 and increased fluorescence intensity of BAI1 (P<0.01). The medium-dose GXSP group exhibited declined serum levels of IL-1β, TNF-α, TC, LDL-C, and MDA (P<0.01), increased activity of SOD (P<0.05), upregulated expression of α-SMA, AXL, MERTK, TYRO3, and MFGE8 (P<0.05, P<0.01), downregulated expression of JNK, NF-κB p65, p38 MAPK, and ERK1/2 (P<0.01), reduced fluorescence intensity of CD68 and enhanced fluorescence intensity of BAI1 (P<0.01). The low-dose GXSP group demonstrated lowered serum levels of IL-1β, TNF-α, and TC (P<0.01), upregulated expression of AXL, MERTK, TYRO3, and MFGE8 (P<0.05, P<0.01), downregulated expression of JNK, NF-κB p65, p38 MAPK, and ERK1/2 (P<0.01), weakened fluorescence intensity of CD68 and enhanced fluorescence intensity of BAI1 (P<0.01).ConclusionGXSP can mitigate AS plaque formation, lipid metabolism disorders, and inflammatory response in ApoE-/- mice by enhancing macrophage efferocytosis and inhibiting the IL-18/MAPK signaling pathway.Keywords:atherosclerosis;Guanxinshu prescription;inflammatory response;macrophage efferocytosis;interleukin-18 (IL-18)/mitogen-activated protein kinase (MAPK) signaling pathway35|16|0<HTML><H-PDF> <L-PDF> <XML>Updated:2026-11-17Danqi Xinmaikang Attenuates Chronic Heart Failure by Promoting Fatty Acid Oxidation Through Activating AMPK/PGC-1α Signaling Pathway AI Introduction
Abstract:ObjectiveTo investigate the effects of Danqi Xinmaikang (DQ) on chronic heart failure (CHF) induced by left anterior descending (LAD) coronary artery ligation in mice and to explore its molecular mechanism of regulating fatty acid oxidation via the adenosine 5'-monophosphate-activated protein kinase (AMPK) signaling pathway to combat CHF.MethodsA CHF model was established in mice by LAD coronary artery ligation. Mice were randomized into sham, model, positive control (sacubitril valsartan sodium tablets 50 mg·kg-1), and low-dose and high-dose DQ groups(0.64,1.28 g·kg-1), with 6 mice in each group. After successful modeling, drug administration was implemented for 4 consecutive weeks. After drug administration, changes in cardiac function parameters such as left ventricular ejection fraction (LVEF) and left ventricular fractional shortening (LVFS) were measured via cardiac ultrasound. Plasma N-terminal pro-B-type natriuretic peptide precursor (NT-proBNP) levels were determined by enzyme-linked immunosorbent assay (ELISA). Cardiac pathological changes and fibrosis severity were observed via hematoxylin-eosin (HE) staining and Masson staining. Western blot and Real-time quantitative polymerase chain reaction(Real-time PCR) were adopted to determine the protein and mRNA levels, respectively, of AMPK, phosphorylated AMPK (p-AMPK), medium-chain specific acyl-CoA dehydrogenase, mitochondrial (ACADM), carnitine palmitoyltransferase 1A (CPT1A), fatty acid translocase (CD36), and peroxisome proliferator-activated receptor γ co-activator 1α (PGC-1α). In vitro experiments employed oxygen-glucose deprivation (OGD) to treat cardiomyocytes, with control, OGD model group, and low-, medium-, and high-dose (1, 3, and 5 g·L-1, respectively) DQ groups established. The expression of relevant molecules in each group was assessed via Western blot and Real-time PCR. AMPK inhibitor Compound C (CC) was further used to verify the role of AMPK pathway in the protective effect of DQ.ResultsCompared with the sham group, the model group exhibited reduced LVEF and LVFS (P<0.05) and an elevated plasma NT-proBNP level (P<0.05), along with significant pathological damage and fibrosis in the myocardial tissue. Compared with the model group, 4 weeks of DQ treatment improved LVEF and LVFS (P<0.05), decreased the plasma NT-proBNP level (P<0.05), and alleviated myocardial fibrosis and pathological damage. In vitro experiments similarly demonstrated that DQ significantly enhanced the cell viability of OGD-treated H9c2 cells compared with the OGD group(P<0.05). Further mechanism studies revealed that DQ, both in vitro and in vivo, promoted AMPK phosphorylation and increased mRNA and protein levels of PGC-1α and fatty acid oxidation-related molecules (ACADM, CPT1A, and CD36) (P<0.05). The AMPK inhibitor Compound C reversed these effects of DQ (P<0.05).ConclusionDanqi Xinmaikang effectively improves the cardiac function in the mouse model of LAD ligation-induced CHF, reduces myocardial injury and fibrosis, and exhibits significant protective effects against OGD-induced cardiomyocyte damage. It activates the AMPK/PGC-1α signaling pathway to promote fatty acid oxidation, thereby ameliorating myocardial energy metabolism disorders. In this study, DQ was associated with ischemic heart failure, providing experimental basis for CHF treatment, suggesting that it has the potential to be a candidate drug for CHF treatment.Keywords:Danqi Xinmaikang;chronic heart failure (CHF);adenosine 5′-monophosphate-activated protein kinase (AMPK) signaling pathway;fatty acid metabolism;peroxisome proliferator-activated receptor γ co-activator 1α (PGC-1α)55|22|0<HTML><H-PDF> <L-PDF> <XML>Updated:2026-11-17- Abstract:Changyanning granulesConba® is derived from a long-standing empirical prescription and is a product of Jiangxi Conba Tianshikang Pharmaceutical Co., Ltd. It is included in the Category B of the National Drug Catalogue for Basic Medical Insurance, Work-related Injury Insurance and Maternity Insurance. Composed of five medicinal herbs including Euphorbiae Humifusae Herba and Hedyotis chrysotricha (Palib.) Merr., Changyanning granules have the effects of clearing heat, draining dampness, and promoting Qi movement. Clinically, it is used for acute and chronic gastroenteritis, diarrhea, bacillary dysentery, infantile dyspepsia and other diseases. At present, this drug lacks unified standards for clinical application, and the understanding of its efficacy, suitable syndromes, and safety remains insufficient. To clarify the standards for clinical application and promote rational drug use, a consensus working group was established with 32 experts in the fields of gastroenterology, pharmacy, and evidence-based medicine. Through expert interviews, nominal group technique, and questionnaire surveys, 21 core clinical issues were sorted out and identified. After a systematic review of relevant literature, the evidence level was evaluated by the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach, and finally the Expert Consensus on Clinical Application of Changyanning granulesConba® was formed. This Consensus was registered internationally in both Chinese and English in August 2025, with the registration number PREPARE-2025CN1248. It has been reviewed and approved by the China Ethnic Medicine Association and officially released on the National Group Standard Information Platform (T/CEMA 052—2025). This consensus is applicable to physicians and pharmacists of traditional Chinese medicine (TCM), Western medicine, and integrated Chinese and Western medicine in medical and health institutions at all levels nationwide. The consensus clarifies that the indicated TCM syndrome of this drug is the stomach-intestine dampness-heat syndrome, standardizes the usage, dosage, treatment course, and dosage adjustment for special populations with different syndromes, defines the applicable scenarios of monotherapy and combined medication, and specifies the adverse reactions, contraindications, and precautions. Modern research shows that this drug has definite therapeutic effects on off-label indications such as infantile rotavirus enteritis, irritable bowel syndrome, and ulcerative colitis. This consensus provides a scientific basis for the rational clinical use of Changyanning granulesConba®, improving the therapeutic effect and reducing medication risks, and will be continuously revised and improved based on new clinical problems and evidence-based medicine in the future.Keywords:expert consensus;Changyanning granules;clinical application;gastroenteritis;diarrhea;infantile dyspepsia103|64|0<HTML><H-PDF> <L-PDF> <XML>Updated:2026-11-17
Compilation Explanation for Expert Consensus on Clinical Application of Changyanning GranulesConba® AI Introduction
Abstract:To standardize the clinical application of Changyanning granulesConba®, address clinical practice issues such as inconsistent dosage selection, ambiguous indicated syndromes, and off-label use, and improve medication efficacy and safety, the Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences led the joint development of the Expert Consensus on Clinical Application of Changyanning granulesConba® with 28 institutions across China. This consensus formulation strictly adheres to the WHO Handbook for Guideline Development, the Directives for Standardization—Part 1: Rules for the Structure and Drafting of Standardizing Documents (GB/T 1.1—2020), and the Compilation Specifications for Expert Consensus on Clinical Application of Chinese Patent Medicines, adopting a 10-step closed-loop development process. Through systematic literature retrieval, multi-source information including clinical research evidence, expert practical experience, and industry standards were integrated. After online-offline collaborative discussions and voting by 32 cross-disciplinary experts, 21 core clinical questions were finally confirmed, along with 7 recommendation opinions and 28 consensus suggestions. Comprehensive evidence shows that Changyanning granulesConba®, either used alone or in combination with conventional therapy, has definite efficacy in treating conditions such as diarrhea and infantile dyspepsia, with good safety, low incidence of adverse reactions, and mild severity. This consensus integrates evidence-based medicine with the characteristics of traditional Chinese medicine syndrome differentiation and treatment, clarifying the application scope, dosage, usage, combined medication scenarios, and precautions. It provides a standardized reference for clinicians and pharmacists in medical institutions at all levels, and plays a guiding role in promoting the standardized clinical application of Changyanning granulesConba® and ensuring medication safety.Keywords:Changyanning granules;expert consensus;Conba;compilation explanation;clinical application75|25|0<HTML><H-PDF> <L-PDF> <XML>Updated:2026-11-17Effect of Sinitang Combined with Targeted Therapy and Immunotherapy on Enterohepatic Circulation of Bile Acid in Patients with Liver Cancer AI Introduction
Abstract:ObjectiveTo observe the clinical efficacy of Sinitang combined with lenvatinib mesylate and sintilizumab in treating liver cancer and the effects on the cholesterol metabolism and intestinal flora structure in the patients, thus preliminarily exploring the regulatory effect on hepatoenteric circulation of bile acid.MethodsEighty liver cancer patients treated in Suzhou Hospital of Traditional Chinese Medicine were selected and randomly allocated to control and observation groups, with 40 patients in each group. The control group was treated with lenvatinib mesylate combined with sintilimab, and the observation group additionally received Sinitang granules for three months. The Karnofsky Performance Status (KPS) score, traditional Chinese medicine (TCM) syndrome efficacy, TCM syndrome score, and computed tomography/magnetic resonance imaging (CT/MRI) imaging results of the two groups before and after treatment were compared. The serum levels of total cholesterol (TC), triglyceride (TG), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), and total bile acid (TBA) were assayed. The 16S rDNA sequencing technique was used to detect the changes of intestinal flora structure characteristics and the correlation between differential taxa and TBA in the two groups before and after treatment.ResultsAfter treatment, the KPS scores of the two groups increased (P<0.05,P<0.01), and the change was more pronounced in the observation group (P<0.01). Following treatment, TCM symptom scores in the observation group declined (P<0.01). The total response rate of TCM syndrome alleviation in the observation group was 82.50%(33/40), exceeding that (55.00%, 22/40) of the control group (χ2=7.040, P<0.05). Post-treatment CT/MRI findings in the observation group tended to be better than those in the control group, although the inter-group difference did not reach statistical significance. After treatment, the observation group showed increases in the number of gut microbial taxa at the phylum, order, family, genus, and species levels (P<0.05). In addition, the observation group exhibited declined serum TC, TG, and LDL-C levels (P<0.05) and TBA level (P<0.01), whereas the HDL-C level increased slightly. After Sinitang treatment, the diversity of intestinal flora in patients with liver cancer increased. The relative abundance of Comamonas decreased, and that of f__Planococcaceae_Unclassified, differed significantly before and after treatment,while f__Oscillospiraceae_Unclassified, and Christensenellaceae_R-7_group increased (P<0.05). The differential bacterial species demonstrated a strong correlation with TBA (P<0.05).ConclusionSinitang combined with targeted therapy and immunotherapy can improve the clinical status of patients with liver cancer and regulate cholesterol metabolism and intestinal flora structure by regulating the enterohepatic circulation of bile acid.Keywords:Sinitang;liver cancer;intestinal flora;bile acid;cholesterol metabolism;16S rDNA54|21|0<HTML><H-PDF> <L-PDF> <XML>Updated:2026-11-17- Abstract:ObjectiveTo observe the clinical efficacy of Yanghe Dingchuan prescription combined with budesonide and formoterol inhalation in the treatment of stable chronic obstructive pulmonary disease (COPD).MethodsA randomized, double-blind, placebo-controlled trial was conducted, in which 86 patients were randomly assigned into a treatment group and a control group, with 43 patients in each group. Both groups received COPD disease education and chronic disease management. On this basis, the treatment group was treated with oral Yanghe Dingchuan prescription combined with budesonide and formoterol inhalation, while the control group was treated with oral Yanghe Dingchuan Prescription placebo combined with budesonide and formoterol inhalation for 12 weeks. The main efficacy indicators of two groups were determined before and after treatment, including pulmonary function indicators [forced vital capacity (FVC), forced expiratory volume in one second (FEV1), and the ratio of forced expiratory volume in one second to forced vital capacity (FEV1/FVC%)]. Secondary efficacy indicators included traditional Chinese medicine (TCM) symptom scores, modified Medical Research Council (mMRC) score, 6-minute walking distance (6MWD), COPD self-assessment test (CAT) score, levels of inflammatory factors [interleukin-1β ( IL-1β) and tumor necrosis factor-α (TNF-α)], hemorheological parameters (high shear viscosity, low shear viscosity, plasma viscosity, and fibrinogen), and incidence of adverse reactions.ResultFinally, 80 patients were included for analysis, with 39 patients in the control group and 41 patients in the treatment group. There was no statistically significant difference in baseline data between the two groups of patients. After treatment, both groups showed decreased FVC, FEV1, FEV1/FVC%, mMRC score, CAT score, IL-1β and TNF-α levels, high shear viscosity, low shear viscosity, plasma viscosity, fibrinogen, and TCM symptom scores and increased 6MWD (P<0.05). The treatment group outperformed the control group in terms of FVC, FEV1, FEV1/FVC%, mMRC score, CAT score, IL-1β and TNF-α levels, high shear viscosity, low shear viscosity, plasma viscosity, fibrinogen and scores of TCM symptoms, such as wheezing, shortness of breath, cough, expectoration, cold limbs, susceptibility to colds, and tinnitus (P<0.05), while there was no statistically significant difference in the scores of fatigue, soreness and weakness of the waist and knees, and frequent urination at night. The total response rate of the treatment group was 92.68% (38/41), which was higher than that (76.92%, 30/39) of the control group (χ2=3.894, P<0.05). Neither the treatment group nor the control group experienced significant adverse reactions during the treatment period.ConclusionThe combination of Yanghe Dingchuan prescription with budesonide and formoterol inhalation can effectively alleviate clinical symptoms, enhance exercise tolerance and quality of life, protect the lung function, reduce airway inflammation, and promote blood circulation, and it has good safety in the treatment of stable COPD.Keywords:chronic obstructive pulmonary disease;stationary phase;Yanghe Dingchuan prescription;budesonide and formoterol inhalation;clinical efficacy56|18|0<HTML><H-PDF> <L-PDF> <XML>Updated:2026-11-17
- Abstract:ObjectiveTo explore the clinical efficacy and safety of Jianpi Qinghua prescription on autoimmune hepatitis (AIH) in patients with the spleen deficiency and stasis-heat syndrome and its effect on the gut microbiota.MethodsA randomized controlled study was conducted. Seventy-two AIH patients with the spleen deficiency and stasis-heat syndrome were selected from the Department of Gastroenterology and Hepatology of the First Affiliated Hospital of Henan University of Chinese Medicine and randomized into an experimental group and a control group, with 36 patients in each group. The control group received basic treatment with Western medicine, and the experimental group additionally received oral administration of Jianpi Qinghua prescription. The treatment lasted for 12 weeks. The traditional Chinese medicine (TCM) symptom scores, liver function indicators, and immunity indicators were determined before and after treatment in both groups. In the experimental group, 16 patients were randomly selected, and 16S rRNA sequencing was employed to determine the gut microbiota changes before and after the treatment.ResultsAfter treatment, the clinical comprehensive efficacy and TCM symptom efficacy in the experimental group were 88.89%(32/36) and 94.44%(34/36), respectively, which were higher than those 69.44%(25/36) vs. 77.78%(28/36) in the control group (P<0.05). After treatment, the experimental group had lower TCM symptom scores, liver enzyme indicators [alanine aminotransferase (ALT), aspartate aminotransferase (AST), adenosine deaminase (ADA), alkaline phosphatase (ALP), and gamma-glutamyl transpeptidase (GGT)], immunoglobulin G (IgG), immunoglobulin M (IgM), and liver metabolism indicators [globulin (GLB), total bile acids (TBA), total bilirubin (TBIL), and indirect bilirubin (IDBIL)] (P<0.05), but higher liver synthesis indicators [albumin (ALB) and cholinesterase (CHE)] (P<0.05) than the control group. In terms of safety indicators, compared with the control group, the experimental group exhibited decreases in blood routine indicators [white blood cells (WBC), red blood cells (RBC), and hemoglobin (HGB)] and incidence of adverse reactions (P<0.05). The results of 16S rDNA sequencing showed significant changes in the diversity of gut microbiota of AIH patients after treatment with Jianpi Qinghua prescription. After treatment, the patients in the experimental group showed increased relative abundance of Firmicutes, Proteobacteria, and Acidobacteria at the phylum level (P<0.05), increased relative abundance of Clostridia and decreased relative abundance of Proteobacteria and Bacilli at the class level (P<0.05), decreased relative abundance of Enterobacteriales and Lactobacillales and increased relative abundance of Oscillospirales and Lachnospirales at the order level (P<0.05), decreased relative abundance of Enterobacteriaceae and Streptococcaceae and increased relative abundance of Lachnospiraceae and Ruminococcaceae at the family level (P<0.05), and decreased relative abundance of Escherichia-Shigella, Streptococcus, Veillonella, and Lactobacillus and increased relative abundance of Faecalibacterium, Aerobacter, and Megamonas at the genus level (P<0.05). The phylogenetic tree showed that the relative abundance of Clostridia, Firmicutes, Oscillospirales, and Ruminalococcaceae increased in the patients of the experimental group after treatment (P<0.05).ConclusionJianpi Qinghua prescription can effectively reduce the levels of liver enzyme indexes, immunoglobulins, and liver metabolism indicators, and increase the levels of liver synthesis indicators in AIH patients with the spleen deficiency and stasis-heat syndrome, and the mechanism may be related to the regulation of the gut microbiota.Keywords:Jianpi Qinghua prescription;autoimmune hepatitis;clinical efficacy;gut microbiota71|27|0<HTML><H-PDF> <L-PDF> <XML>Updated:2026-11-17
- Abstract:ObjectiveTo compare the intestinal absorption characteristics of eleven constituents (protocatechuic acid, tiliroside, scutellarin, luteoloside, astragaline, epicatechin, catechin, methoxsalen, p-coumaric acid, caffeic acid, and apigenin-7-O-glucuronide) of Rubus multibracteatus extract in normal and inflammatory pain model rats via a peristalsis-intestinal perfusion model.MethodsThe extract was administered at concentrations of 25.0, 50.0, 100.0 g·L-1, and the levels of the eleven components in intestinal perfusion samples were quantified by ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS). The remaining drug quantity Ptn(μg) and cumulative absorption-transformation rate A(%) over 2 h were calculated to compare the intestinal absorption characteristics of each component in normal and inflammatory pain model rats.ResultsNone of the components exhibited dose-dependent increases, suggesting non-simple absorption mechanisms. For other components except catechin and epicatechin, the model group showed better absorption in the jejunum, while the normal group exhibited superior absorption in the duodenum. The cumulative absorption rates in the duodenum, ileum, and at low concentrations were generally higher in normal rats than in model rats.ConclusionInflammatory pain alters the intestinal absorption of R. multibracteatus extract, and further research is needed to elucidate the underlying mechanisms.Keywords:Rubus multibracteatus extract;peristalsis-intestinal perfusion model;inflammatory pain model rats;intestinal absorption characteristics;ultra performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS)35|23|0<HTML><H-PDF> <L-PDF> <XML>Updated:2026-11-17
PK-PD Profiling of Active Components in Eucommia ulmoides Extract with Aortic Vascular Endothelial Cells from SHR Model AI Introduction
Abstract:ObjectiveTo establish a pharmacokinetic-pharmacodynamic (PK-PD) model of active components in Eucommia ulmoides at the cellular level under pathological state for clarifying the compounds related to the antihypertensive effect of E. ulmoides.MethodsQualified spontaneous hypertensive rat (SHR) models were selected. Rat primary aortic vascular endothelial cells (VECs) were separated and cultured by the method of ligation and adherence. After subculture and successful identification, the cells were used to conduct the next experiment. The cells were cultured in 6-well plates at a density of 5×104 cells/mL, and the culture medium containing E. ulmoides extract (3 g·L-1) was added to each well. The cells and cell supernatant were collected at different time points. The levels of nitric oxide (NO) and angiotensin Ⅱ (AngⅡ) in the cell supernatant were determined. The ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) method was used to determine the levels of seven active components in E. ulmoides extract at different time points. For each active component of E. ulmoides, according to the data characteristics of cell PK and PD at different time points, the PK parameters were fixed, and then WinNonlin 8.2 software was used to select an appropriate model to fit the PD data, and thus the PK-PD models of active components in E. ulmoides were built.ResultsThe absorption of chlorogenic acid and pinoresinol glucoside was faster in VECs, while that of pinoresinol diglucoside and neochlorogenic acid in VECs was slower. Pinoresinol diglucoside, geniposidic acid, and pinoresinol glucoside were eliminated slowly in VECs, while protocatechuic acid, chlorogenic acid, neochlorogenic acid, and cryptochlorogenic acid were eliminated quickly in VECs. Among the components of E. ulmoides extract in VECs, the pharmacological indicator NO showed the lowest half-maximal effective concentration/half-maximal inhibitory concentration (EC50/IC50) value.ConclusionThe active components in E. ulmoides exhibit strong affinity for NO and exert a rapid regulatory effect on NO. Increasing the release of NO in the body may be a key mechanism by which E. ulmoides exerts its antihypertensive effect.Keywords:Eucommia ulmoides;Vascular endothelial cell;pharmacokinetics;pharmacokinetic-pharmacodynamic model59|24|0<HTML><H-PDF> <L-PDF> <XML>Updated:2026-11-17PK-PD Profiling of Active Components in Eucommia ulmoides Under Different Physiological and Pathological Conditions AI Introduction
Abstract:ObjectiveTo establish a pharmacokinetic-pharmacodynamic (PK-PD) model of active components in Eucommia ulmoides at the animal level under pathological state for clarifying the compounds directly related to the antihypertensive effect of E. ulmoides.MethodsHealthy Wistar rats and qualified spontaneously hypertensive rat (SHR) models were selected and administrated with E. ulmoides extract (5.4 g·kg-1) each day by gavage once daily for six consecutive days. The, the rats were subjected to jugular vein cannulation and administrated with E. ulmoides extract (5.4 g·kg-1) the next day. Blood samples (0.5 mL each) were collected at different time points before and after the administration, and the plasma was separated. Subsequently, the levels of nitric oxide (NO), endothetin-1 (ET-1), and angiotensin Ⅱ (AngⅡ) in the plasma of the SHR models at different time points were determined by biochemical assay kits for PD research. UPLC-MS/MS was then employed to determine the levels of seven active components of E. ulmoides extract in plasma of SHR model and Wistar rats at different time points. The plasma concentration-time curve and main pharmacokinetic parameters of each component were obtained for PK research. Then, the PK parameters were fixed by WinNonlin 8.2 software, and a suitable model was selected to fit the PD data. Thus, the PK-PD models of active components in E. ulmoides were constructed.ResultsCompared with the normal group, the SHR model showed decreases in half-life (t1/2), apparent volume of distribution (Vz/F), and mean residence time (MRT0-∞) of (+)-pinoresinol di-O-β-D-glucopyranoside (PDG) after repeated gavage of E. ulmoides extract. In the model group, genipinic acid (GA) showed reduced t1/2, area under curve (AUC0-t), and MRT0-∞ but increased clearance (CLss/F), and (+)-pinoresinol 4′-O-β-D-glucopyranoside (PG) exhibited shortened t1/2. Protocatechuic acid (PCA) in the model group showed prolonged t1/2. Chlorogenic acid (CA) exhibited prolonged t1/2, decreased AUC0-t, and increased Vz/F and CLss/F in the model group. The MRT0-∞ of cryptochlorogenic acid (CCA) was shortened in the model group. In summary, there were significant differences in the pharmacokinetic process of PDG, GA, PG, PCA, CA, and CCA in the E. ulmoides extract. Among the three PD indicators AngⅡ, ET-1, and NO, NO had the lowest half-maximal effective concentration/half-maximal inhibitory concentration (EC50/IC50) value.ConclusionThere are differences in the PK process of the active components of E. ulmoides extract between normal rats and SHR models. Hypertension will change the PK behavior of the active components in E. ulmoides extract.Keywords:Eucommia ulmoides extract;spontaneously hypertensive rats;pharmacokinetics;pharmacokinetic-pharmacodynamic model64|20|0<HTML><H-PDF> <L-PDF> <XML>Updated:2026-11-17- Abstract:ObjectiveTo investigate the pharmacokinetics of six active components-scutellarin, baicalein, oroxylin A, geniposide, oroxylin A glucuronide, and baicalin-in Shuganning injection following single and multiple doses in rats, thus comparing the pharmacokinetics of Shuganning injection at different doses and under different dosing regimens.MethodsFirstly, ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) was employed to establish a method for simultaneous determination of six active components-scutellarin, baicalein, oroxylin A, geniposide, oroxylin A glucuronide, and baicalinin—in rat plasma. Then, SD rats were assigned into a single-dose group and a multiple-dose group according to different dosing regimens. Each of the single-dose group and multiple-dose group were designed with low, medium, and high concentrations for tail vein injection. The rats were subjected to jugular vein cannulation, and blood samples were collected from the jugular vein at different time points before and after administration of Shuganning injection the next day, transferred into heparinized Eppendorf tubes, and centrifuged to separate plasma. Finally, the UPLC-MS/MS method was employed to determine the plasma concentrations of six active components at different time points. WinNonlin 8.2 software was used to analyze the pharmacokinetic parameters.ResultsA UPLC-MS/MS method was established for simultaneous determination of scutellarin, baicalein, oroxylin A, geniposide, oroxylin A glucuronide, and baicalinin in rat plasma and to study the pharmacokinetic characteristics at low, medium, and high concentrations after tail vein injection of Shuganning injection with single and multiple doses. The method verified that the linear relationship of each component in rat plasma samples was good (R2>0.995). The extraction recovery and matrix effect ranged from 92.12% to 112.48%. The intra-day and inter-day precision, accuracy, and stability met the requirements of biological sample analysis. For single-dose administration, the area under curve (AUC0-t) values of the six components increased with the increase in concentration, suggesting that the six components showed dose-dependent pharmacokinetic characteristics in vivo. For multiple-dose administration, compared with the single-dose group, at low concentrations, the AUC0-t and AUC0-∞ of baicalein increased, and the mean residence time (MRT0-∞) of the other five components except oroxylin A glucoronide prolonged. At medium concentrations, AUC0-t and AUC0-∞ increased, and clearance (CL) decreased. At high concentrations, the AUC0-t and AUC0-∞ of baicalein and geniposide increased, and the increase in AUC0-t may be due to the fact that the previous drug has not been completely eliminated at the next administration, resulting in a certain accumulation. It is hypothesized that the plasma concentration of Shuganning injection in SD rats may accumulate to a certain extent after seven consecutive days of administration once a day.ConclusionShuganning injection in different concentrations and different dosing regimens exhibit pharmacokinetic differences, which provides a theoretical basis for the clinical application of Shuganning Injection.Keywords:Shuganning injection;SD rats;ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS);pharmacokinetics66|37|0<HTML><H-PDF> <L-PDF> <XML>Updated:2026-11-17
- Abstract:ObjectiveTo compare the content of ephedrine and pseudoephedrine among different parts of Ephedra sinica and to screen and functionally verify short-chain dehydrogenase/reductase (SDR) genes involved in the asymmetric synthesis.MethodsThe content of ephedrine and pseudoephedrine in herbaceous stems and rhizomes of E. sinica was determined by ultra-high performance liquid chromatography-tandem triple quadrupole mass spectrometry (UHPLC-QqQ-MS). Transcriptome sequencing was employed to screen differentially expressed SDR genes participating in the asymmetric synthesis and conduct bioinformatics analysis. Gas chromatography-mass spectrometry (GC-MS) combined with chiral liquid chromatography was further adopted to complete the in vitro functional verification of candidate genes.ResultsEphedrine (1.85-2.66 mg·g-1) and pseudoephedrine (1.02-1.71 mg·g-1) were detected in herbaceous stems, while neither of them was detected in rhizomes. A total of 161 979 unigenes were obtained by transcriptome assembly, among which 781 SDR family genes were identified. Compared with rhizomes, herbaceous stems showed significant upregulation of 17 288 genes (including 125 genes encoding SDR members). The most highly expressed gene EsSDR_DN57015 encoded a stable, slightly alkaline soluble protein with no signal peptide or transmembrane structure but the typical structural characteristics of the SDR family. In vitro functional verification showed that the encoded enzyme could catalyze the asymmetric reduction of 2-chloroacetophenone, with stereoselectivity biased toward S-configuration and an enantiomeric excess (ee) value of -35.05%.ConclusionThis study confirmed that ephedrine and pseudoephedrine accumulate mainly in the herbaceous stems of E. sinica. A candidate SDR gene EsSDR_DN57015 involved in asymmetric reduction was screened and functionally verified, which provides a theoretical basis for elucidating the stereoselective formation mechanism of ephedrine alkaloids and facilitating high-quality breeding of E. sinica.Keywords:Ephedra sinica;ephedrine;pseudoephedrine;transcriptomics;asymmetric biosynthesis;short-chain dehydrogenase/reductase52|17|0<HTML><H-PDF> <L-PDF> <XML>Updated:2026-11-17
- Abstract:ObjectiveTo identify shared core targets by integrating plasma proteomics with the separation index of betweenness (SAB) and to investigate the common pathological mechanism underlying the syndrome of intermingled phlegm and stasis in coronary heart disease (CHD) and ischemic stroke (IS), with a particularly focus on mitochondrial apoptosis.MethodsApoE-/- mice were fed a high-fat diet and subjected to left anterior descending coronary artery ligation for the modeling of CHD with the syndrome of intermingled phlegm and stasis, while SD rats were fed a high-fat diet and subjected to middle cerebral artery occlusion (MCAO) for the modeling of IS with the same syndrome. The serum lipid profiles and coagulation parameters in rats were measured by an automated biochemical analyzer, and the serum lipids and myocardial enzymes in mice were assessed by enzyme-linked immunosorbent assay (ELISA). Cardiac function in mice was evaluated by small-animal echocardiography, and neurological deficits in rats were scored through the Zea-Longa method. The cerebral infarct volume was determined by 2,3,5-triphenyltetrazolium chloride(TTC) staining, and histopathological changes in the heart and brain tissue were examined by hematoxylin-eosin (HE) staining. High-throughput proteomics was employed to construct protein expression profiles for both diseases. The SAB index was calculated to assess module separation, and a protein-protein interaction network was constructed to identify shared core targets. Western blot was employed to validate the expression levels of core proteins-proteasome subunit beta 8 (PSMB8), proteasome subunit beta 5 (PSMB5), and aldolase B (ALDOB)-as well as mitochondrial apoptosis-related proteins including B-cell lymphoma-2 (Bcl-2), Bcl-2-associated X protein (Bax), and cleaved cysteinyl-specific proteinase 3 (Caspase-3). Terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) staining was performed to assess cardiomyocyte and neuronal apoptosis.ResultsCompared with the control group, the mouse model of CHD with the syndrome of intermingled phlegm and stasis exhibited systolic and diastolic dysfunctions, myocardial cell atrophy, and elevated myocardial enzyme levels. The rat model of IS with the syndrome of intermingled phlegm and stasis showed significant neurological deficits, increased cerebral infarct volume, and neuronal degeneration/necrosis. Proteomic analysis combined with SAB screening identified PSMB8, PSMB5, and ALDOB as shared core proteins in both CHD and IS with the same syndrome. The expressions of three proteins were all significantly decreased in myocardial tissues of CHD mice and brain tissues of ischemic stroke rats(P<0.05). Additionally, the modeling upregulated the expression of pro-apoptotic proteins Bax and cleaved Caspase-3, while downregulating the expression of the anti-apoptotic protein Bcl-2, resulting in an increased Bax/Bcl-2 ratio (P<0.05). TUNEL staining confirmed that the apoptosis rates of cardiomyocytes in coronary heart disease mice and brain neurons in ischemic stroke rats were both significantly increased(P<0.05).ConclusionPSMB8, PSMB5, and ALDOB may serve as shared core proteins in CHD and IS with the syndrome of intermingled phlegm and stasis. Their downregulation likely contributes to mitochondrial apoptosis, thereby promoting injury to both cardiomyocytes and neurons, which may represent a common pathological mechanism underlying the syndrome in the two cardiovascular-cerebrovascular diseases.Keywords:coronary heart diseases;ischemic stroke;syndrome of intermingled phlegm and stasis;common pathological mechanisms;separation index of betweenness73|19|0<HTML><H-PDF> <L-PDF> <XML>Updated:2026-11-17
Identification and Expression Analysis of GATA Transcription Factor Gene Family in Aesculus chinensis AI Introduction
Abstract:ObjectiveTo identify and functionally characterize the GATA gene family members in Aesculus chinensis at the whole-genome level, thus providing a reference for exploring the biological functions of these genes in A. chinensis.MethodsThe conserved GATA domain PF00320 was retrieved from the InterPro database, and a hidden Markov model was constructed via HMMER. The gathering threshold (GA, sequence cutoff=26.8, domain cutoff=26.8) was used as the screening criterion. GATA family members were searched against the proteome of A. chinensis based on its high-quality genome, and AcGATA members were identified with conserved domain validation. Bioinformatic tools including TBtools-Ⅱ v2.485, ExPASy, MEME, WoLF PSORT, and IQ-TREE were adopted to systematically analyze the physicochemical properties, subcellular localization, conserved domains, chromosomal distribution, gene structure, phylogeny, and cis-acting elements of AcGATA members.ResultsA total of 33 GATA genes were identified, distributed across 18 chromosomes, all possessing the type Ⅳb zinc finger domain. Thirty AcGATAs were predicted to localize in the nucleus. Phylogenetic analysis classified AcGATAs into four classes, among which Class A contained the largest number of members, and the gene structure was conserved within the same class. The combined results of transcriptomic, phylogenetic, and cis-element analyses suggested that AcGATA02, AcGATA03, AcGATA06, AcGATA09, AcGATA10, AcGATA13, AcGATA19, AcGATA27, AcGATA29, and AcGATA30 might participate in seed development or the transcriptional regulation of aescin biosynthesis in A. chinensis.ConclusionThirty-three AcGATA genes were identified in the A. chinensis genome, among which 10 candidates likely involved in seed development or aescin biosynthesis regulation were screened as targets for further functional validation.Keywords:GATA transcription factor;Aesculus chinensis;gene family identification;expression mode;secondary metabolites57|21|0<HTML><H-PDF> <L-PDF> <XML>Updated:2026-11-17- Abstract:ObjectiveTo compare the effects of three processing methods—freeze drying (FD), shade drying (SD), and fresh cutting followed by low-temperature drying (LTD)—in production areas on the quality of Angelicae Sinensis Radix decoction pieces.MethodsAngelicae Sinensis Radix samples from Minxian County, Gansu Province were processed with the three methods. The content of chlorogenic acid, ferulic acid, senkyunolides I, H, and A, ligustilide, and butylidenephthalide was determined by high performance liquid chromatography(HPLC). The total volatile oil content was measured with the method specified in the Chinese Pharmacopeia. The oil cavity characteristics were observed via paraffin sections. Antioxidant activity was evaluated by 2,2-diphenyl-1-picrylhydrazyl (DPPH) and 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt (ABTS) assays. The blood-tonifying efficacy was assessed with a phenylhydrazine-induced anemia model in zebrafish. Multivariate statistical analysis, Spearman correlation analysis, and entropy-weighted TOPSIS were employed for comprehensive quality evaluation.ResultsThe three processing methods significantly affected both chemical components and efficacy of Angelicae Sinensis Radix. Samples prepared by LTD retained the highest overall content of the seven components, followed by FD, with SD retained the lowest component content. Total volatile oil content was similar between SD (1.06%-1.60%) and LTD (1.00%-1.90%) samples, slightly lower in FD samples (1.05%-1.36%). Orthogonal partial least squares-discriminant analysis (OPLS-DA) identified ligustilide, butylidenephthalide, senkyunolides, and ferulic acid as key differential components distinguishing the three processing methods. For antioxidant activity, SD samples exhibited better IC50 values for scavenging DPPH (0.524 g·L-1) and ABTS (0.338 g·L-1) than the other two groups. The zebrafish assay showed that the high-dose FD group had the strongest blood-tonifying effect, followed by the high-dose SD group. The entropy-weighted TOPSIS integrating antioxidant and blood-tonifying activities ranked the three processing methods as SD>FD>LTD.ConclusionSD demonstrated the best performance in preserving active components and maintaining antioxidant and blood-tonifying activities. Therefore, SD is recommended as the preferred processing method for Angelicae Sinensis Radix in production areas.Keywords:Angelicae Sinensis Radix;processing methods in production area;antioxidant activity;blood-tonifying efficacy;multivariate statistical analysis3|0|0<HTML><H-PDF> <L-PDF> <XML>Updated:2026-11-17
Analysis and Construction of Animal Models of Hepatocellular Carcinoma Based on Data Mining AI Introduction
Abstract:ObjectiveTo explore the key influencing factors and evaluation standards involved in the rat modeling of hepatocellular carcinoma (HCC), providing a theoretical basis for the scientific evaluation of experimental methods and drug efficacy in animal studies of HCC.MethodsA systematic review was conducted on 300 Chinese articles related to mouse and rat models of HCC that were published from January 2022 to December 2024, as well as the English articles published. Data mining was employed to extract key parameters (such as animal species, modeling methods, positive drugs, and detection indicators), and corresponding models were constructed based on these parameters.ResultsIn the modeling of HCC, the commonly used animals included BALB/c mice (30.33%), C57BL/6 mice (25.00%), SD rats (13.00%), and KM mice (12.67%). For in situ modeling of HCC, chemical induction with diethylnitrosamine (DEN, 16.33%) was frequently employed. In transplant tumor modeling, intrahepatic injection was the main method, with common cell lines such as Hepa1-6 (2.33%) and H22 (2.00%). Subcutaneous tumor models were mainly established by subcutaneous injection of HCC cells, mainly H22(18.67%) and HepG2 (9.33%). In experiments, cisplatin, cyclophosphamide, and 5-fluorouracil were frequently selected as positive drugs. The most common detection indicators included histological changes observed through HE staining (167 times), protein expression (160 times), and cytokine levels (156 times). Experimental results indicated that in the modeling with DEN + Carbon tetrachloride (CCl4), SD rats demonstrated greater model stability than KM mice, providing a quantitative basis for optimizing animal models of HCC.ConclusionWhen the DEN + CCl4 chemical induction method is adopted to establish an HCC model, SD rats are a superior experimental species over KM mice, as their model exhibits significant advantages in pathological accuracy, process predictability, and relevance to human disease. It is recommended that 4- to 6-week-old male KM mice or 6- to 8-week-old male SD rats can be used as the model animals, depending on specific needs, and the chemical stimulation method can be used for model establishment. This approach can efficiently and effectively replicate pathological features similar to human HCC, thereby serving as a reference for animal experiments in HCC research.Keywords:hepatocellular carcinoma;animal model;data mining;model construction61|23|0<HTML><H-PDF> <L-PDF> <XML>Updated:2026-11-17- Abstract:Malignant tumors, classified as cancer diseases in traditional Chinese medicine (TCM), are characterized by core pathogenic mechanisms including Yin-Yang imbalance, deficiency of healthy Qi with excess of pathogenic factors, and dysregulation of Qi movement, posing challenges to clinical treatment. Although the Important Prescriptions Worth a Thousand Gold for Emergency (Qian Jin Fang), the earliest extant medical encyclopedia in China, does not specifically address tumors, its compatibility principles offer valuable insights for modern oncology. This paper examines six representative formulas-Weijing Tang, Sanwu Huangqin Tang, Duhuo Jisheng Tang, Wendan Tang, Xijiao Dihuang Tang, and Wenpi Tang-from the text and analyzes their application in oncology. The study identifies three core formulation principles embodied in these formulas. The first is balancing cold and warm properties to harmonize Yin and Yang. This is exemplified by Wenpi Tang and Xijiao Dihuang Tang, which regulate Yin-Yang balance through the combination of cold and warm herbs. The second is simultaneously tonifying and purging to consolidate the root and resolve masses. Representative formulas include Duhuo Jisheng Tang and Sanwu Huangqin Tang, achieving organic integration of reinforcing healthy Qi and eliminating pathogens. The third is regulating Qi movement to restore normal Qi transformation, illustrated by Wendan Tang and Weijing Tang, which recovers Zang-Fu organ functions by rectifying Qi movement. These formulation principles align closely with the complex pathogenesis of tumors characterized by Yin-Yang imbalance, deficient healthy Qi with excess pathogens, and disrupted Qi movement. They demonstrate unique advantages in treating modern refractory malignancies such as lung cancer, colorectal cancer, bone metastatic cancer, brain tumors, and leukemia. Modern Pharmacological research further confirms that the active components within these formulas possess multiple effects, including inhibiting tumor proliferation and modulating the immune microenvironment. By systematically elucidating the compatibility characteristics and clinical utility of these classical formulas, this study provides both theoretical and practical guidance for TCM oncology, highlighting the strength of TCM in holistic regulation and dynamic equilibrium, thereby contributing to the advancement and innovation of TCM in cancer therapy.Keywords:Important Prescriptions Worth a Thousand Gold for Emergency (Qian Jin Fang);pattern identification and treatment for cancer;compatibility characteristics;balancing cold and warm properties;simultaneously tonifying and purging;regulating Qi movement51|38|0<HTML><H-PDF> <L-PDF> <XML>Updated:2026-11-17
Syndrome Differentiation and Treatment of Premature Ovarian Insufficiency Based on "Xuanfu-Qiye-Luomai" Theory AI Introduction
Abstract:Premature ovarian insufficiency (POI) is characterized by a decline in ovarian function before the age of 40 years, with clinical manifestations including menstrual changes, reduced fertility, and hypoestrogenic symptoms. In traditional Chinese medicine (TCM), POI is commonly treated from the perspectives of kidney deficiency, liver constraint, and blood stasis. However, the relationships among impaired Qiye movement, insufficient nourishment of the Baogong, and disturbed distribution through the Luomai have not been fully elucidated. According to the "Xuanfu-Qiye-Luomai" theory, Xuanfu serve as the portals for the ascending, descending, entering, and exiting of Qiye. Qiye constitutes the fundamental material basis for nourishing the Zang-fu organs and body structures. Luomai form a network of pathways for the permeation and circulation of Qiye. From this perspective, although POI is rooted in kidney essence deficiency and insufficiency of Tiangui, its pathogenesis is not characterized by deficiency alone. Emotional constraint and dysfunction of the liver in governing free flow of Qi may lead to Qi stagnation and dysfunction of Xuanfu opening and closing in the Baogong. With prolonged Xuanfu constraint, Qiye may gradually shift from obstruction to insufficiency, resulting in inadequate nourishment of the Baogong and ovarian follicles. Persistent Qiye depletion may lead to insufficient blood and sluggish circulation, which, together with Qi stagnation and cold coagulation, may gradually give rise to Luomai stasis, hinder the delivery of refined substances to the Baogong, and contribute to disease lingering. These pathological processes interact with one another, resulting in the coexistence of constraint, insufficient nourishment, and stasis. At the microscopic level, these pathological changes may be considered in parallel with impaired oocyte-granulosa cell communication, restricted metabolic support within the follicular microenvironment, reduced ovarian blood perfusion, and stromal fibrosis. Therapeutically, the core principles are to unblock Xuanfu, nourish Qiye, and free the Luomai. Xuanfu constraint should be treated by soothing the liver, opening Xuanfu, and regulating the ascending and descending of Qi. Qiye insufficiency should be treated by tonifying fluids, moistening Xuanfu, and nourishing the Baogong; Luomai stasis should be treated by replenishing essence to consolidate the root and resolving stasis to free the Luomai. This theoretical framework supplements the understanding of POI pathogenesis from the perspectives of Qiye movement, Baogong nourishment, and Luomai distribution, providing a new approach to TCM syndrome differentiation and treatment of POI and related conditions such as diminished ovarian reserve and poor ovarian response.Keywords:premature ovarian insufficiency;Xuanfu;Qiye;Luomai;Baogong41|27|0<HTML><H-PDF> <L-PDF> <XML>Updated:2026-11-17- Abstract:According to the spatiotemporal evolution of cancer collaterals, this paper proposes that deficiency of Qi and Yin in the lung collaterals, together with latent cancer toxin, constitutes the root cause of recurrence and metastasis of small cell lung cancer (SCLC). The combination of phlegm, stasis, and toxin, accompanied by collateral damage and toxin overflow, marks the pivotal transition. Aberrant regeneration of cancer collaterals, accompanied by toxin dissemination to multiple Zang-organ collaterals, represents the subsequent transformation. Although SCLC often responds to initial treatment, latent toxin may persist in the lung collaterals after visible tumor masses have regressed. Radiotherapy and chemotherapy consume Qi and Yin, impair the nourishment of normal collaterals, and allow the accumulation of phlegm, stasis, and toxin, driving cancer collaterals from latency to hyperactivity. This process reflects disordered Yin-Yang Qi transformation: insufficient Yang transformation into Qi in normal collaterals coexists with hyperactive Yang movement in cancer collaterals and excessive Yin formation. Temporally, the disease evolves through latent toxin with collateral deficiency, gradual combination of phlegm and stasis, reactivation of latent toxin, and regeneration of cancer collaterals. Spatially, cancer toxin spreads from the lung collaterals through the Qi, blood, and water collaterals and subsequently lodges in the brain, liver, bone, adrenal gland, pleura, and other Zang-organ collaterals. Regulating Qi movement and resolving collaterals is the general therapeutic principle. Before recurrence, treatment should consolidate collaterals and intercept dissemination by restoring Qi transformation, protecting Zang-organ collaterals, monitoring subtle changes in disease momentum, and eliminating latent toxin. After recurrence and metastasis, treatment should resolve collaterals and control disease momentum by differentiating the involved Zang-organ collaterals, relieving collateral obstruction, resolving cancer toxin, protecting healthy Qi, and coordinating with modern anticancer therapy. The core lies in advancing prevention and treatment forward to the stage when latent toxins have not yet emerged and the collaterals just begin to show signs of damage, and adjusting tonification, elimination, unblocking, and astringency based on the metastatic site and treatment tolerance after recurrence. This approach integrates post-treatment remission, recurrence, and metastasis into a continuous disease course and establishes a framework that stages disease by cancer-collateral state, assesses disease momentum by the rise and fall of Qi transformation, identifies dissemination routes through the three collaterals, and determines treatment according to deficiency and excess in Zang-organ collaterals. It may provide a theoretical basis for whole-course traditional Chinese medicine prevention and treatment, as well as clinical evaluation of SCLC.Keywords:theory of cancer collaterals;small cell lung cancer;recurrence and metastasis;spatiotemporal evolution;core pathogenesis;regulating Qi movement and resolving collaterals38|38|0<HTML><H-PDF> <L-PDF> <XML>Updated:2026-11-17
Understanding and Handling of Toxic Chinese Materia Medica in Textbooks During Republic of China Era AI Introduction
Abstract:The Republic of China era was a crucial stage for the scientific and systematic reconstruction of traditional herbal knowledge under the impact of Western medicine and pharmacy. The understanding and handling of toxic Chinese materia medica reflect the characteristics of integrating Chinese and Western knowledge and connecting ancient and modern wisdom. As an important carrier of this process, the textbooks of Chinese materia medica during the Republic of China era, on the basis of inheriting the inherent knowledge of traditional toxic Chinese materia medica, actively absorbed new knowledge from disciplines such as pharmacognosy, Chinese materia medica chemistry, and Chinese materia medica pharmacology, and constructed a knowledge system of toxic Chinese materia medica with the logical approach of "recognizing toxicity-using toxicity-controlling toxicity-detoxifying." Specifically, in terms of recognizing toxicity, the textbooks' explanation of the meaning of toxicity is more inclined towards toxic and side effects, while emphasizing the analysis of the chemical components and pharmacological effects of toxic Chinese materia medica. In the aspect of using toxicity, while emphasizing the efficacy of medicines, the textbooks paid more attention to clinical adaptability and regional characteristics. In controlling toxicity, guarantees for safe medication were provided through improving processing methods, perfecting compatibility, strictly specifying contradictions, and standardizing dosages. In detoxifying, attempts were made to combine Chinese and Western methods to promote the diversified integration of detoxifying strategies. The construction of this knowledge system not only shows that a drug safety ideology covering recognizing toxicity, using toxicity, controlling toxicity, and detoxifying was initially formed during the Republic of China era but also provides guidance and reference for the modern rational use of toxic Chinese materia medica.Keywords:toxic Chinese materia medica;toxic herbal medicines;Chinese materia medica;textbook50|19|0<HTML><H-PDF> <L-PDF> <XML>Updated:2026-11-17Exploration of Integrative Chinese and Western Medicine Treatment Strategies for Cerebellar Ataxia AI Introduction
Abstract:Cerebellar ataxia (CA) is a group of neurological disorders characterized by postural-gait instability,limb incoordination,dysarthria,dysphagia,and oculomotor abnormalities. With complex acquired,hereditary,and neurodegenerative etiologies,its treatment remains challenging. This article proposes an integrative Chinese and Western medicine framework of "core symptoms-traditional Chinese medicine (TCM) disease category-core pathogenesis-basic syndrome pattern-treatment selection" and explores subtype-specific treatment strategies. The core manifestations—postural-gait instability,limb incoordination,shaking vision,dysarthria,trembling,and muscle atrophy—of CA correspond to Guyao,Fengfei,Xuanyun,Yinfei,Chanzheng,and Weizheng in TCM,respectively. Kidney essence deficiency and governor vessel malnutrition are regarded as the root pathogenesis,with phlegm-stasis obstruction,endogenous wind-fire disturbance,spleen-kidney deficiency,and dampness-heat toxin as common accompanying factors. Western medical treatment integrates etiological control,symptomatic therapy,and rehabilitation,while TCM treatment selects herbal medicine,acupuncture-moxibustion,and Daoyin exercises with the effects of tonifying the kidney and supplementing essence,dredging governor vessel and regulating spirit,resolving phlegm and eliminating statis,extinguishing wind and dredging collaterals,and invigorating the spleen and replenishing Qi according to major symptoms and syndrome patterns. For different main symptoms and syndrome patterns under the same subtype,different prescriptions and acupuncture regimens can be selected based on the disease stage,the severity of the main symptom,the presence of pathogenic excess,and the involved area. This study provides a basis for developing integrative treatment strategies for CA from both theoretical and clinical perspectives.Keywords:cerebellar ataxia;integrative Chinese and western medicine;treatment strategy;exploration66|56|0<HTML><H-PDF> <L-PDF> <XML>Updated:2026-11-17- Abstract:Ventricular remodeling after myocardial infarction is one of the major factors leading to cardiovascular events. Pyroptosis, as a newly discovered form of programmed cell death in recent years, has been proven to play a key role in the excessive inflammatory response and malignant remodeling of myocardial damage after myocardial infarction. Modern research has shown that in the pathological process of ventricular remodeling after myocardial infarction, pyroptosis is induced by pathways such as NOD-like receptor thermal protein domain associated protein 3 (NLRP3) inflammasome/gasdermin D (GSDMD)/lipopolysaccharide (LPS), and excessive pyroptosis can further aggravate the metabolic imbalance and inflammatory response, forming a vicious cycle. Harmful hyperactivity and responding inhibition is a classic theory in traditional Chinese medicine (TCM) that explains human pathophysiological phenomena and guides clinical treatment. According to the connotation of classic TCM theory and pathogenesis and the research achievements of modern physiology, pathology, and molecular biology, this paper believes that the pathological mechanism of pyroptosis in ventricular remodeling after myocardial infarction corresponds to the theoretical connotation of harmful hyperactivity and responding inhibition. Targeting the pathological mechanism and characteristics of pyroptosis, this paper further proposes the general treatment principle of restraining the hyperactivity and balancing the excess, and explores the potential mechanisms of TCM intervention in pyroptosis. The study found that various TCM active ingredients and compound formulas can inhibit the activation of inflammatory factors and the expression of inflammatory proteins by regulating inflammation-related signaling pathways such as Toll-like receptors/nuclear factor-kappa B (TLRs/NF-κB) and NLRP3/GSDMD pathways, thereby reducing inflammatory response. In summary, according to the theory of harmful hyperactivity and responding inhibition, this paper sorts out the influence and connection of pyroptosis mechanism in ventricular remodeling after myocardial infarction and makes an outlook on the possible path of prevention and treatment with TCM, providing a reference for the research and clinical application of integrated traditional Chinese and Western medicine.Keywords:harmful hyperactivity and responding inhibition;pyroptosis;myocardial infarction;ventricular remodeling62|21|0<HTML><H-PDF> <L-PDF> <XML>Updated:2026-11-17
- Abstract:Chronic atrophic gastritis (CAG) is a major precancerous stage in the gastric carcinogenesis cascade. Its prolonged course and progression toward precancerous lesions of gastric cancer are closely associated with persistent chronic inflammation of the gastric mucosa, glandular atrophy, impaired damage repair, and disruption of cellular homeostasis. Autophagy is an essential mechanism for cellular quality control, substrate degradation, and material recycling. Imbalance of autophagic homeostasis may lead to insufficient clearance of damaged substrates, persistent inflammatory oxidative stress, impaired autophagy-lysosome degradation, and abnormal repair and renewal, thereby participating in the progression of CAG and precancerous lesions of gastric cancer. The theory of spleen-stomach Qi transformation centers on orderly ascending and descending of Qi, mutual dependence of reception and transformation, harmony between dryness and dampness, and orderly exit and entrance, emphasizing the generation of nutrient essence, transformation of clear and turbid Qi, nourishment of gastric collaterals, and the interaction between healthy Qi and pathogenic factors. During the progression of CAG, dysfunction of spleen-stomach Qi transformation may manifest as malnourishment of gastric collaterals, retention of turbidity and stasis, lingering pathogenic factors, and insufficient repair. Its association with autophagic homeostasis is mainly reflected in shared pathological processes, including disruption of gastric mucosal homeostasis, insufficient clearance of damaged substrates, impaired repair and renewal, and precancerous evolution. From the spleen-stomach Qi transformation theory, this paper reviews the role of autophagic homeostasis imbalance in the occurrence and development of CAG and the progression of precancerous lesions discusses the mechanism interpretation between spleen-stomach Qi transformation dysfunction and autophagic homeostasis imbalance is discussed, and summarizes the research progress in traditional Chinese medicine (TCM) restoring of spleen-stomach Qi transformation and correction of autophagic homeostasis. This review aims to provide a theoretical basis for the prevention and treatment of CAG and the delay of precancerous lesion progression with TCM.Keywords:chronic atrophic gastritis;precancerous lesions of gastric cancer;spleen-stomach Qi transformation;autophagic homeostasis imbalance;traditional Chinese medicine52|14|0<HTML><H-PDF> <L-PDF> <XML>Updated:2026-11-17
Traditional Chinese Medicine Intervenes in Endoplasmic Reticulum Stress for Treating Dilated Cardiomyopathy: A Review AI Introduction
Abstract:Dilated cardiomyopathy (DCM) is a type of primary cardiomyopathy characterized by ventricular dilatation and impaired systolic function, with an extremely poor prognosis. Current Western medical treatments can only slow disease progression and are unable to reverse irreversible myocardial damage. Accumulating studies in recent years have confirmed that persistent and excessive activation of endoplasmic reticulum stress (ERS) is one of the key pathological hubs mediating myocardial injury in DCM. Through the abnormal cascade of the three unfolded protein response (UPR) signaling pathways—protein kinase RNA-like endoplasmic reticulum kinase (PERK), inositol-requiring enzyme 1α (IRE1α), and activating transcription factor 6 (ATF6)—ERS drives three core pathological processes: cardiomyocyte apoptosis, myocardial fibrosis, and calcium homeostasis disruption. It has now emerged as a highly promising novel therapeutic target in DCM treatment. Chemical drugs targeting ERS have limitations such as single-target specificity and difficulties in clinical translation. Traditional Chinese medicine (TCM), characterized by multi-component, multi-target, and holistic regulation, has demonstrated potential application advantages in the prevention and treatment of DCM. This paper systematically elucidates the physiological basis and core regulatory pathways of ERS, delves into the key mechanisms through which ERS mediates the pathological progression of DCM, and summarizes the latest advances in basic research on the targeted regulation of ERS for DCM treatment with TCM formulas, single herbs, active components, Chinese patent medicines, modern TCM preparations, and TCM injections. Finally, it summarizes the existing shortcomings of current research and outlines future research directions, aiming to provide preliminary theoretical support and a clear research framework for the precision prevention and treatment of DCM with TCM.Keywords:dilated cardiomyopathy;endoplasmic reticulum stress;traditional Chinese medicine;unfolded protein response;apoptosis57|26|0<HTML><H-PDF> <L-PDF> <XML>Updated:2026-11-17Community Assembly and Antagonism Mechanisms of Rhizosphere Biocontrol Microorganisms for Disease Suppression in Medicinal Plants AI Introduction
Abstract:The continuous cropping obstacles of medicinal plants seriously constrain the sustainable development of the Chinese medicinal material industry. A key contributing factor of continuous cropping obstacles is the long-term monoculture-caused imbalance in rhizosphere microbial composition. Rhizosphere biocontrol microorganisms, as "natural guardians" of the plant micro-ecosystem, help restore ecological balance through multiple mechanisms such as pathogen suppression, plant growth promotion, and induced systemic resistance, offering a promising approach to alleviating continuous cropping obstacles. This paper systematically elucidates the assembly mechanisms of rhizosphere biocontrol microbial communities of medicinal plants, with an emphasis on the signaling role of root exudates in the directional recruitment of microorganisms. It further addresses the synergistic regulatory effects of key factors—including soil physicochemical properties, host genetic characteristics, and microbial adaptability—on the structures and functions of biocontrol microbial communities. Additionally, the study clarifies five synergistic mechanisms by which biocontrol microorganisms antagonize pathogens: Nutrient and spatial competition, parasitism, formation of protective layers, secretion of antimicrobial compounds, and induction of plant systemic resistance, thereby constructing a disease-suppression network encompassing physical, chemical, and immune layers. In response to the limitations such as poor colonization capacity, narrow antagonistic spectra, and low stability of single-strain biocontrol agents in field applications, this paper innovatively proposes a tripartite collaborative strategy of "detoxification-growth promotion-quality improvement" though composite microbial consortia. By modulating the root exudate-microorganism interaction network, this approach synergistically enhances stress resistance and bioactive compound accumulation in medicinal plants, providing both a theoretical foundation and a technical pathway for the ecological cultivation of genuine medicinal plants.Keywords:medicinal plants;continuous cropping obstacle;rhizosphere biocontrol agents;microbial community assembly;antagonism mechanisms57|22|0<HTML><H-PDF> <L-PDF> <XML>Updated:2026-11-17





















































